SCHEMBL2304429

SCHEMBL2304429

CCCCCC(=O)CP(=O)(OC)OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
MAPT P10636 1/20 0.45
CES2 O00748 4/20 0.43
CES1 P23141 4/20 0.43
AKR1B1 P15121 1/20 0.41
HAO1 Q9UJM8 1/20 0.41
GPR84 Q9NQS5 7/20 0.40
PPARG P37231 7/20 0.40
PPARD Q03181 7/20 0.40
PPARA Q07869 7/20 0.40
HDAC11 Q96DB2 5/20 0.40
TSHR P16473 4/20 0.40
PTPN1 P18031 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TLR2 O60603 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
FABP4 P15090 2/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11623313 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL7950973 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL2302039 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL11626606 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL7563843 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL7947906 0.98 KMT2A (0.48) KMT2AMAPTCES2CES1HAO1
SCHEMBL7714477 0.94 CES1 (0.41) KMT2AMAPTCES2CES1AKR1B1
SCHEMBL17673047 0.91 TSHR (0.45) KMT2AMAPTHAO1TSHRALDH1A1
SCHEMBL28191042 0.86 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL10826323 0.85 LMNA (0.38) CES2CES1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US claimed
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP claimed
WO-2023034354-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2023-03-09 WO claimed
CN-112979599-A Preparation method of carboprost tromethamine intermediate 河北赛谱睿思医药科技有限公司 2021-06-18 CN claimed
EP-0144459-A1 Prostaglandins, their preparation and pharmaceutical compositions Dr. Willmar Schwabe GmbH & Co. (DE) 1985-06-19 EP claimed
EP-0113561-A2 Prostaglandin intermediates, their synthesis and their conversion to prostaglandins THE UPJOHN COMPANY (US) 1984-07-18 EP claimed
US-4176122-A Process for the preparation of bicyclic enone compounds CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK (HU) 1979-11-27 US claimed
US-4052407-A ENZYME INHIBITORS, MULTISTAGE GYOGYSZERKUTATO INTEZET (HU) 1977-10-04 US claimed
US-3992439-A ESTERIFICATION, ACYLATION, HYDROGENATION, OXIDATION, HYDROLYZING PFIZER INC. (US) 1976-11-16 US claimed
JP-63216866-A None JP disclosed
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US disclosed
WO-2024190777-A1 TRICYCLIC COMPOUND 小野薬品工業株式会社 2024-09-19 WO disclosed
WO-2024190780-A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR KIDNEY DISEASES CONTAINING TRICYCLIC COMPOUND 小野薬品工業株式会社 2024-09-19 WO disclosed
US-20240287105-A1 TREPROSTINIL ANALOGS AND RELATED METHODS OF MAKING AND USING UNITED THERAPEUTICS CORPORATION (US) 2024-08-29 US disclosed
US-3950359-A PROSTAGLANDINS AND METHODS OF MAKING SAME MERCK & CO., INC. (US) 1976-04-13 US disclosed
US-3947469-A PROSTAGLANDIN INTERMEDIATES RECHERCHE ET INDUSTRIE THERAPEUTIQUES (R.I.T.) (BE) 1976-03-30 US disclosed
US-3939182-A Prostaglandin E1 intermediate 6α-carboxy-5α(1-hydroxyethyl)-2-cyclohexene-1-heptanoic acid,γ-lactone, and lower alkyl or aralkyl esters thereof MERCK & CO., INC. (US) 1976-02-17 US disclosed
US-3935254-A 5C-PROSTEN-13-YNOIC ACIDS CARLO ERBA S.P.A. (IT) 1976-01-27 US disclosed
US-3931297-A 10-Hydroxy PGC compounds SYNTEX (U.S.A.) INC. (US) 1976-01-06 US disclosed
US-3931279-A 5-Oxa prostaglandin F2.sub.α analogs THE UPJOHN COMPANY (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287105-A1 TREPROSTINIL ANALOGS AND RELATED METHODS OF MAKING AND USING TYMP, TTPA, PTGIS KMT2A 3470/4885MAPT 3498/4885CES2 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.